Vestal Point Capital, LP Bristol Myers Squibb CO Transaction History
Vestal Point Capital, LP
- $1.32 Trillion
- Q3 2024
A detailed history of Vestal Point Capital, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vestal Point Capital, LP holds 250,000 shares of BMY stock, worth $14 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
250,000
Previous 500,000
50.0%
Holding current value
$14 Million
Previous $20.8 Billion
37.71%
% of portfolio
0.98%
Previous 1.55%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,671Shares Held
1.47BCall Options Held
31.9MPut Options Held
35.3M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.37 Billion0.44% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.2 Billion0.2% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...